8.07
price down icon1.05%   -0.06
 
loading
Schlusskurs vom Vortag:
$8.13
Offen:
$8.19
24-Stunden-Volumen:
264.24K
Relative Volume:
0.04
Marktkapitalisierung:
$2.10B
Einnahmen:
$6.28B
Nettoeinkommen (Verlust:
$700.00M
KGV:
2.9975
EPS:
2.6922
Netto-Cashflow:
$537.00M
1W Leistung:
+11.12%
1M Leistung:
+15.76%
6M Leistung:
-18.82%
1J Leistung:
-49.72%
1-Tages-Spanne:
Value
$8.015
$8.29
1-Wochen-Bereich:
Value
$7.175
$8.49
52-Wochen-Spanne:
Value
$6.18
$17.23

Organon Co Stock (OGN) Company Profile

Name
Firmenname
Organon Co
Name
Telefon
551-430-6000
Name
Adresse
30 HUDSON STREET, JERSEY CITY
Name
Mitarbeiter
10,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
OGN's Discussions on Twitter

Vergleichen Sie OGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
OGN
Organon Co
8.06 2.11B 6.28B 700.00M 537.00M 2.6922
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,103.72 971.27B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
206.06 495.71B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
224.11 396.12B 59.64B 2.36B 19.68B 1.3253
Drug Manufacturers - General icon
MRK
Merck Co Inc
112.39 275.48B 63.90B 19.05B 13.05B 7.5596
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
142.76 271.43B 54.45B 14.42B 17.15B 7.333

Organon Co Stock (OGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-09 Eingeleitet Barclays Underweight
2025-10-27 Herabstufung Piper Sandler Overweight → Underweight
2025-05-02 Herabstufung Evercore ISI Outperform → In-line
2024-09-06 Herabstufung JP Morgan Neutral → Underweight
2023-11-03 Herabstufung Goldman Buy → Neutral
2023-09-21 Eingeleitet Barclays Overweight
2023-03-16 Eingeleitet Raymond James Outperform
2022-10-14 Herabstufung BofA Securities Neutral → Underperform
2022-09-06 Hochstufung Piper Sandler Neutral → Overweight
2022-08-05 Herabstufung BofA Securities Buy → Neutral
2022-04-27 Eingeleitet Goldman Buy
2022-04-06 Fortgesetzt Morgan Stanley Equal-Weight
2021-10-07 Eingeleitet Piper Sandler Neutral
2021-09-01 Eingeleitet BofA Securities Buy
2021-07-22 Eingeleitet Citigroup Buy
2021-06-15 Eingeleitet JP Morgan Neutral
2021-06-11 Eingeleitet Morgan Stanley Equal-Weight
2021-06-10 Eingeleitet Evercore ISI Outperform
Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

pulisher
01:11 AM

Assessing Organon (OGN) Valuation After Short Term Share Price Momentum And Long Term Weak Returns - Yahoo Finance UK

01:11 AM
pulisher
Jan 08, 2026

Organon poised to extend rally to seventh consecutive session - MSN

Jan 08, 2026
pulisher
Jan 08, 2026

Assessing Organon (OGN) Valuation After New Nilemdo Cholesterol Therapy Agreement - simplywall.st

Jan 08, 2026
pulisher
Jan 08, 2026

Organon, Daiichi Sankyo Europe enter commercialization pact for Nilemdo - TipRanks

Jan 08, 2026
pulisher
Jan 08, 2026

Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo®? in France, Denmark, Iceland, Sweden, Finland and Norway - MarketScreener

Jan 08, 2026
pulisher
Jan 08, 2026

Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway - Yahoo! Finance Canada

Jan 08, 2026
pulisher
Jan 07, 2026

Organon Named Top Dividend Stock With Insider Buying and 0.99% Yield (OGN) - Nasdaq

Jan 07, 2026
pulisher
Jan 07, 2026

Organon & Co. (OGN) Stock Analysis: Exploring The 25.77% Potential Upside For Investors - DirectorsTalk Interviews

Jan 07, 2026
pulisher
Jan 06, 2026

Is Organon (NYSE:OGN) A Risky Investment? - 富途牛牛

Jan 06, 2026
pulisher
Jan 06, 2026

Organon & Co. Sees Unusually Large Options Volume (NYSE:OGN) - MarketBeat

Jan 06, 2026
pulisher
Jan 06, 2026

Great week for Organon & Co. (NYSE:OGN) institutional investors after losing 51% over the previous year - simplywall.st

Jan 06, 2026
pulisher
Jan 05, 2026

Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance

Jan 05, 2026
pulisher
Jan 05, 2026

Samsung Bioepis Denies Organon Deal Rumors - Citeline News & Insights

Jan 05, 2026
pulisher
Jan 04, 2026

Samsung Bioepis pursues direct sales by weighing Organon acquisition to boost profitsCHOSUNBIZ - Chosunbiz

Jan 04, 2026
pulisher
Jan 04, 2026

Samsung Bioepis reviews Organon acquisition to boost direct biosimilar salesCHOSUNBIZ - Chosunbiz

Jan 04, 2026
pulisher
Jan 03, 2026

Mixed Martial Arts Group Limited Stock Analysis and ForecastTechnical Resistance Breaks & Stay One Step Ahead of Risk Events - earlytimes.in

Jan 03, 2026
pulisher
Jan 03, 2026

Organon & Co. (NYSE:OGN) Upgraded at Wall Street Zen - MarketBeat

Jan 03, 2026
pulisher
Jan 02, 2026

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - sharewise.com

Jan 02, 2026
pulisher
Jan 02, 2026

Understanding the Setup: (OGN) and Scalable Risk - Stock Traders Daily

Jan 02, 2026
pulisher
Dec 30, 2025

Will Organon Co 7XP stock outperform value peersMarket Growth Report & Fast Exit and Entry Trade Guides - moha.gov.vn

Dec 30, 2025
pulisher
Dec 30, 2025

Volume Summary: How Organon Co stock reacts to inflationary pressuresBreakout Watch & Expert-Curated Trade Recommendations - moha.gov.vn

Dec 30, 2025
pulisher
Dec 25, 2025

Does Organon’s 50% Share Price Slide Signal Opportunity in 2025? - Yahoo Finance

Dec 25, 2025
pulisher
Dec 25, 2025

Gilman Hill Asset Management LLC Reduces Position in Organon & Co. $OGN - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - sharewise.com

Dec 24, 2025
pulisher
Dec 22, 2025

Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know - sharewise.com

Dec 22, 2025
pulisher
Dec 22, 2025

Why (OGN) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Dec 22, 2025
pulisher
Dec 19, 2025

Organon: Deep Value With No Clear Catalysts (NYSE:OGN) - Seeking Alpha

Dec 19, 2025
pulisher
Dec 18, 2025

Pharma co Organon inks VPPA with Schneider Electric for solar in Spain - Renewables Now

Dec 18, 2025
pulisher
Dec 17, 2025

Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - TMX Newsfile

Dec 17, 2025
pulisher
Dec 17, 2025

Organon & Co. (NYSE:OGN) Given Average Recommendation of "Reduce" by Analysts - MarketBeat

Dec 17, 2025
pulisher
Dec 17, 2025

OGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Dec 17, 2025
pulisher
Dec 16, 2025

Organon pushes for sustainable investment in women’s health across Africa - The Business & Financial Times

Dec 16, 2025
pulisher
Dec 16, 2025

TetraScience and Organon Collaborate to Modernize Quality Control Data Management - 富途牛牛

Dec 16, 2025
pulisher
Dec 15, 2025

3 Healthcare Stocks with Questionable Fundamentals - The Globe and Mail

Dec 15, 2025
pulisher
Dec 14, 2025

Organon Launches Phase 3 Study on Tapinarof Cream for Atopic Dermatitis in Infants - TipRanks

Dec 14, 2025
pulisher
Dec 13, 2025

How Investors Are Reacting To Organon (OGN) As Barclays Joins Growing Analyst Skepticism - Sahm

Dec 13, 2025
pulisher
Dec 13, 2025

Why Analysts See Organon’s Story Shifting Amid Governance Concerns And Lower Valuations - Yahoo Finance

Dec 13, 2025
pulisher
Dec 12, 2025

Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance

Dec 12, 2025
pulisher
Dec 12, 2025

Organon & Co. $OGN Stake Lessened by Globeflex Capital L P - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Organon Shares Under Pressure Following Critical Analyst Review - AD HOC NEWS

Dec 12, 2025
pulisher
Dec 11, 2025

Can Organon’s Steep 2025 Share Price Slide Signal a Long Term Opportunity? - simplywall.st

Dec 11, 2025
pulisher
Dec 11, 2025

Organon pushes bold women’s health agenda at WHX Leaders’ Summit in Accra - MyJoyOnline

Dec 11, 2025
pulisher
Dec 11, 2025

Les billets sont maintenant en vente pour Importance Vitale : sommet national sur la santé des femmes - GlobeNewswire Inc.

Dec 11, 2025
pulisher
Dec 11, 2025

Why Organon (OGN) shares are trading lower today - MSN

Dec 11, 2025
pulisher
Dec 11, 2025

New York State Common Retirement Fund Sells 353,330 Shares of Organon & Co. $OGN - MarketBeat

Dec 11, 2025
pulisher
Dec 10, 2025

Understanding Momentum Shifts in (OGN) - news.stocktradersdaily.com

Dec 10, 2025
pulisher
Dec 10, 2025

Investors in Organon & Co. (OGN): Protect Your RightsContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire

Dec 10, 2025
pulisher
Dec 10, 2025

Organon & Co. (NYSE:OGN) Stock Rating Upgraded by Barclays - MarketBeat

Dec 10, 2025
pulisher
Dec 10, 2025

Organon & Co. $OGN Shares Bought by Cerity Partners LLC - MarketBeat

Dec 10, 2025
pulisher
Dec 10, 2025

WHX Africa Leaders Summit: Organon Unveils Multi-Sector Approach to Women’s Health in Africa - News Ghana

Dec 10, 2025
pulisher
Dec 09, 2025

Barclays Initiates Coverage of Organon (OGN) with Underweight Recommendation - Nasdaq

Dec 09, 2025

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general SNY
$49.12
price up icon 1.97%
drug_manufacturers_general PFE
$25.41
price up icon 0.49%
$121.81
price up icon 0.79%
$330.81
price up icon 0.02%
drug_manufacturers_general NVO
$60.38
price up icon 5.06%
drug_manufacturers_general NVS
$142.78
price up icon 0.92%
Kapitalisierung:     |  Volumen (24h):